A clinical trial demonstrates that a novel personalized mRNA-based vaccine triggers a strong immune response against glioblastoma, extending survivability in trial patients.

A comprehensive look at the clinical validation of exagamglogene autotemcel, the first CRISPR-based gene editing therapy approved for sickle cell disease.

How ultra-thin brain-computer interfaces are enabling paralyzed individuals to control robotic limbs and communicate with microscopic latency.